Efficacy of monoclonal antibodies association in presence of two sars-cov-2 dominant variant of concern. comparative study versus monotherapy against a single variant: a real experience in umbria, italy.

ConclusionsOur data are in line with other experiences drawn from real life but show a higher hospitalization risk than that observed in the randomized trials which were performed before the spread of VOCs

Source: Mediterranean Journal of Hematology and Infectious Diseases - June 29, 2022 Category: Hematology Authors: Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci Source Type: research